US Patent Issued to MUSC Foundation for Research Development on Sept. 1 for "Endostatin peptides for the treatment of tumors, fibrosis and acute lung injury" (South Carolina Inventor)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,881, issued on Sept. 1, was assigned to MUSC Foundation for Research Development (Charleston, S.C.).

"Endostatin peptides for the treatment of tumors, fibrosis and acute lung injury" was invented by Carol Feghali-Bostwick (Mt. Pleasant, S.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compositions and methods for treatment or prevention of tumor growth, fibrosis, acute lung injury or a combination thereof. In one embodiment, the composition comprises a peptide derived from the C-terminal region of endostatin."

The patent was filed on July 2, 2020, under Application No. 16/919,680.

*For further information, includi...